Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of Dipsacus saponin B in the preparation of drugs for preventing and treating vascular diseases

A kind of technology of saponin B and medicine, applied in the field of medicine

Active Publication Date: 2022-06-21
HUNAN UNIV OF CHINESE MEDICINE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, whether Dipsacus saponin B has an inhibitory effect on vascular remodeling, and how its mechanism of action has not been reported so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Dipsacus saponin B in the preparation of drugs for preventing and treating vascular diseases
  • Application of Dipsacus saponin B in the preparation of drugs for preventing and treating vascular diseases
  • Application of Dipsacus saponin B in the preparation of drugs for preventing and treating vascular diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1 Prediction of network pharmacology on the effect of saponin B on DNA topoisomerase 2a (TOP2a)

[0028] The saponin B used in the embodiment of the present invention was purchased from Nanjing Chunqiu Biological Co., Ltd., and the purity was >98%. Download the structural formula of saponin B from the pubchem database, with a similar score > 0.8 in the ChemMapper database, and the conditions of the BindingDB biological activity library predict the target of saponin B, and download the predicted target. The IGEMDOCK molecular docking software was used to dock saponin B with the target. First, select the active docking site, input the compound for docking, and analyze and score to determine the follow-up research object. The database prediction results are shown in Table 1 and figure 1 .

[0029] Table 1 ChemMapper database to predict the target of saponin B

[0030]

[0031] The results showed that the values ​​of TOP2a, BCL-xL, PYGM and PTGS1 in iGEMDOCK d...

Embodiment 2

[0032] Example 2 Experiment on the inhibition of Ang-II-induced VSMCs cell proliferation by Chuanxu saponin B

[0033] The cell viability was detected by MTT method, and the logarithmic growth phase VSMCs were taken and plated at a density of 8000 cells / well. At the same time, an equal volume of PBS was added to the peripheral wells to avoid the marginalization effect. After 24h, dissolve the saponin B with culture medium, gradient such as: 1, 3, 10, 30, 100, 300, 1000 μM, each empty 100 μL, incubate for 2 hours, then discard, add and then add angiotensin II (Angiotensin II, Ang-II) (1 μM) to induce the proliferation model, incubate together for 24 h, discard, add 100 μL of MTT solution to each well, and continue to incubate for 4 h. Then aspirate the culture medium, add 150 μL DMSO, shake for 10 min on a shaker, and detect the OD value at a wavelength of 570 nm on a microplate reader. see the results figure 2 .

[0034] The results showed that compared with the control g...

Embodiment 3

[0037] Example 3 Chuanxu saponin B inhibits the expression of VSMCs cell proliferation-related proteins induced by Ang-II

[0038] The cells were seeded in a petri dish at 5×105 / ml, and when the cell confluence reached 80%, the cells were treated in the following corresponding groups for 24 hours. The specific grouping is as follows: control group (high glucose medium), model is Ang-II (1 μmol / L) treatment group, positive control is curcumin (Curcumin, Cur) treatment group (Cur, 5 μmol / L) + Ang-II , Chuanxuduansaponin B treatment group Chuanxuduansaponin B (3, 10, 30 μmol / L) + Ang-II. Cell proteins were collected by lysis, and a 10% SDS-polyacrylamide gel was prepared using an SDS-PAGE gel preparation kit; Electrophoresis was performed at 100V for 100 minutes, the gel was placed on the PVDF membrane and placed on a wet transfer membrane, the current was 300mA, and the time was 2 hours. PVDF was placed in TBS-T containing 5% nonfat milk powder, at room temperature for 45 minu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses the use of Dipsacus saponin B in the preparation of drugs for preventing or treating vascular diseases, which provides a new scope for the application of Dipsacapsaponin, and at the same time, the invention also provides a method for preventing and treating blood vessels Drugs for the treatment of diseases, the inventors found that Dipsacus saponin B participates in the process of cell proliferation and vascular remodeling, and has the effect of preventing and treating intimal hyperplasia after vascular injury, so the drug of the present invention is especially suitable for preventing and treating vascular intimal hyperplasia. vascular disease.

Description

technical field [0001] The invention belongs to the field of medicine, and particularly relates to the use of saponin B in the preparation of medicines for preventing or treating vascular diseases. Background technique [0002] Vascular remodeling is the common pathological basis of atherosclerosis, angioplasty, hypertension and other diseases. Studies have shown that vascular remodeling is a series of structural and functional abnormalities caused by changes in the internal and external environment of blood vessels, including cell proliferation, migration, apoptosis, and changes in mechanism components. Stimulation of the internal and external environment produces structural changes, such as the thickening of the wall, the increase in the ratio of the wall to the lumen, and the decrease in the number of tiny arteries, which then lead to abnormal vascular function. Among them, the proliferation and migration of smooth muscle cells (VSMCs) are the most important pathological...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61P9/00
CPCA61K31/7048A61P9/00
Inventor 庹勤慧霍艳杰廖端芳
Owner HUNAN UNIV OF CHINESE MEDICINE